Clinical Trials
4 trialsNCT07029776 2026-03-03
MMulti-Immune HR; Multi-Target Immunotherapy for High-Risk Multiple Myeloma
University of Arkansas
Phase 2 Not yet recruiting
NCT06744894 2024-12-20
SIL as Maintenance Therapy in Multiple Myeloma
Navy General Hospital, Beijing
Phase 2 Not yet recruiting
NCT00777998 2023-10-27
Auto-Allo Tandem Stem Cell Transplantation for Patients With Multiple Myeloma
Universitätsklinikum Hamburg-Eppendorf
Phase 2 Completed
NCT00580372 2016-09-20
UARK 89-001 Phase II Study of Intensive "TOTAL THERAPY" For Untreated or Minimally Treated Patients With Multiple Myeloma
University of Arkansas
Phase 2 Completed